These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 2363120

  • 1. Inhibition by recombinant hirudins of experimental venous thrombosis and disseminated intravascular coagulation induced by tissue factor in rats.
    Freund M, Cazenave JP, Courtney M, Degryse E, Roitsch C, Bernat A, Delebassée D, Defreyn G, Maffrand JP.
    Thromb Haemost; 1990 Apr 12; 63(2):187-92. PubMed ID: 2363120
    [Abstract] [Full Text] [Related]

  • 2. [The pharmacokinetics and pharmacodynamics of recombinant hirudin-2 nasal spray].
    Zhang YJ, Zhang Q, Hou JL, Wang XL, Chen MX.
    Yao Xue Xue Bao; 2006 Mar 12; 41(3):268-71. PubMed ID: 16759001
    [Abstract] [Full Text] [Related]

  • 3. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
    Nawa K, Itani T, Ono M, Sakano K, Marumoto Y, Iwamoto M.
    Thromb Haemost; 1992 Mar 02; 67(3):366-70. PubMed ID: 1322570
    [Abstract] [Full Text] [Related]

  • 4. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1991 Apr 08; 65(4):355-9. PubMed ID: 2057916
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
    Markwardt F, Hauptmann J, Nowak G, Klessen C, Walsmann P.
    Thromb Haemost; 1982 Jun 28; 47(3):226-9. PubMed ID: 7112494
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Antithrombotic actions of argatroban in rat models of venous, 'mixed' and arterial thrombosis, and its effects on the tail transection bleeding time.
    Berry CN, Girard D, Lochot S, Lecoffre C.
    Br J Pharmacol; 1994 Dec 28; 113(4):1209-14. PubMed ID: 7889274
    [Abstract] [Full Text] [Related]

  • 14. The comparative effects of recombinant hirudin (CGP 39393) and standard heparin on thrombus growth in rabbits.
    Agnelli G, Pascucci C, Cosmi B, Nenci GG.
    Thromb Haemost; 1990 Apr 12; 63(2):204-7. PubMed ID: 2363121
    [Abstract] [Full Text] [Related]

  • 15. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
    Aoki Y, Ohishi R, Takei R, Matsuzaki O, Mohri M, Saitoh K, Gomi K, Sugihara T, Kiyota T, Yamamoto S.
    Thromb Haemost; 1994 Apr 12; 71(4):452-5. PubMed ID: 8052962
    [Abstract] [Full Text] [Related]

  • 16. The anticoagulant mechanism of action of recombinant hirudin (CGP 39393) in plasma.
    Lindhout T, Blezer R, Hemker HC.
    Thromb Haemost; 1990 Nov 30; 64(3):464-8. PubMed ID: 2096492
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin.
    Kaiser B, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Nov 30; 115(1-2):41-6. PubMed ID: 2459030
    [Abstract] [Full Text] [Related]

  • 18. Construction and functional evaluation of hirudin derivatives with low bleeding risk.
    Zhang C, Yu A, Yuan B, Dong C, Yu H, Wang L, Wu C.
    Thromb Haemost; 2008 Feb 30; 99(2):324-30. PubMed ID: 18278181
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
    Liu Y, Lu WL, Wang JC, Zhang X, Zhang H, Wang XQ, Zhou TY, Zhang Q.
    J Control Release; 2007 Feb 26; 117(3):387-95. PubMed ID: 17207884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.